Search Results - "Paradiso, Peter R"
-
1
Adult indication 13-valent pneumococcal conjugate vaccine clinical development overview: formulation, safety, immunogenicity (dosing and sequence), coadministration, and efficacy
Published in Expert review of vaccines (31-12-2024)“…There was no 13-valent pneumococcal conjugate vaccine (PCV13) adult antibody concentration threshold regulatory criterion for licensure - unlike the pediatric…”
Get full text
Journal Article -
2
Advances in Pneumococcal Disease Prevention: 13-Valent Pneumococcal Conjugate Vaccine for Infants and Children
Published in Clinical infectious diseases (15-05-2011)“…A 13-valent pneumococcal conjugate vaccine (PCV13), developed with the same chemistry used for the 7-valent PCV vaccine (PCV7) and with the goal of expanding…”
Get full text
Journal Article -
3
Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants
Published in Pediatrics (Evanston) (01-04-1998)“…To determine the safety and immunogenicity of heptavalent pneumococcal saccharide vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) individually conjugated to…”
Get full text
Journal Article -
4
Pneumococcal Conjugate Vaccine for Adults: A New Paradigm
Published in Clinical infectious diseases (15-07-2012)“…A 13-valent pneumococcal conjugate vaccine has been studied in adults aged ≥50 years to compare the immune response to that induced by the 23-valent…”
Get full text
Journal Article -
5
Establishing Government-Operated Vaccine Programs: An Industry Perspective
Published in Clinical infectious diseases (01-03-2006)“…During 2000–2002, shortages of numerous routinely administered pediatric vaccines occurred. The reasons for these shortages were varied, but they included…”
Get full text
Journal Article -
6
Pneumococcal conjugate vaccine in adults: Let's see what happens
Published in Human vaccines & immunotherapeutics (02-07-2016)“…The recent recommendation for the use of the 13-valent pneumococcal conjugate vaccine (PCV13) in adults 65 y of age and older, provides a new tool for…”
Get full text
Journal Article -
7
Safety and Immunogenicity of a Purified F Protein Respiratory Syncytial Virus (PFP-2) Vaccine in Seropositive Children with Bronchopulmonary Dysplasia
Published in The Journal of infectious diseases (01-02-1998)“…Respiratory syncytial virus (RSV) causes serious respiratory illness in preterm children with bronchopulmonary dysplasia. In a prospective randomized…”
Get full text
Journal Article -
8
Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I
Published in Clinical infectious diseases (01-01-2000)“…We analyzed >70 recent data sets to compare the serogroups causing invasive pneumococcal disease (IPD) with those represented in conjugate vaccine…”
Get full text
Journal Article -
9
Challenges in Estimating Efficacy Against Pneumococcal Pneumonia in Children
Published in The Pediatric infectious disease journal (01-04-2012)Get full text
Journal Article -
10
Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children
Published in The Lancet (British edition) (24-03-2001)“…The development of glycoconjugate vaccines for Streptococcus pneumoniae that are effective in very young children has renewed interest in identification of…”
Get full text
Journal Article -
11
The Contribution of Specific Pneumococcal Serogroups to Different Disease Manifestations: Implications for Conjugate Vaccine Formulation and Use, Part II
Published in Clinical infectious diseases (01-01-2000)“…To assess whether certain serogroups of Streptococcus pneumoniae are preferentially associated with specific disease manifestations, we analyzed all recent…”
Get full text
Journal Article -
12
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers
Published in The Pediatric infectious disease journal (01-09-1999)“…OBJECTIVES.The objectives of this study were (1) to determine the safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate (PNCRM7) vaccine in…”
Get full text
Journal Article -
13
Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants
Published in The Pediatric infectious disease journal (01-02-2001)“…BACKGROUND.Following widespread use of conjugate pneumococcal vaccine, Neisseria meningitidis likely will become the leading cause of bacterial sepsis and…”
Get full text
Journal Article -
14
Recent progress in the development of vaccines for infants and children
Published in Vaccine (30-01-2003)“…Infectious agents do not respect national or international boundaries. Attempts to prevent their spread, and the diseases which they cause, involve…”
Get full text
Journal Article Conference Proceeding -
15
Conjugate Vaccines for Streptococcus pneumoniae
Published in Canadian journal of infectious diseases (01-01-1999)Get full text
Journal Article -
16
The future of polio immunization in the United States: are we ready for change?
Published in The Pediatric infectious disease journal (01-08-1996)“…During the past 6 months there has been considerable debate within the infectious disease community about the current and future recommendations for polio…”
Get full text
Journal Article Conference Proceeding -
17
Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants
Published in Pediatrics (Evanston) (01-12-1993)“…To study the safety and immunogenicity of a combined diphtheria-tetanus-pertussis (DTP)-Haemophilus influenzae type b (HbOC) vaccine (TETRAMUNE) in infants as…”
Get full text
Journal Article -
18
Combined Childhood Immunizations
Published in JAMA : the journal of the American Medical Association (07-10-1992)“…To the Editor.—The recent article by Clemens et al1 states the need for care when assessing potential interference in combination of or even simultaneous…”
Get full text
Journal Article -
19
The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants
Published in The Pediatric infectious disease journal (01-05-1995)“…Enzyme-linked immunosorbent assay polyribosyl ribitol phosphate (PRP) antibody responses to Haemophilus influenzae type b conjugate vaccine (HbOC) given at 2,…”
Get more information
Journal Article -
20